Sleep Disorder Connect
  • Saved
Quality of life changes and their predictors in young adult narcolepsy patients after treatment: A real-world cohort study

Quality of life changes and their predictors in young adult narcolepsy patients after treatment: A real-world cohort study

Source : https://www.frontiersin.org/articles/10.3389/fpsyt.2022.956037/full

BackgroundWe conducted a five-year prospective follow-up study to track the real-world quality of life of patients with narcolepsy after medication and analyzed predictors.MethodsThe study ultimately included 157 participants who completed...


Conclusion: Symptom control greatly associates with the quality of life in narcoleptic patients, and medication can play the most important role. Management targeting narcoleptic symptoms, attention impairment, and drug adherence should be provided.

  • Saved
The Number of Monthly Night Shift Days and Depression Were Associated with an Increased Risk of Excessive Daytime Sleepiness in Emergency Physicians in South Korea - PubMed

The Number of Monthly Night Shift Days and Depression Were Associated with an Increased Risk of Excessive Daytime Sleepiness in Emergency Physicians in South Korea - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36004850/

This study aimed to report the prevalence and identify the factors associated with excessive daytime sleepiness (EDS) among emergency physicians in South Korea. We analyzed the Korean Emergency Physicians Survey...


Relevance: This study aimed to report the prevalence and identify the factors associated with excessive daytime sleepiness (EDS) among emergency physicians in South Korea.

  • Saved
Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and/or narcolepsy in five European countries - BMC Neurology

Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and/or narcolepsy in five European countries - BMC Neurology

Source : https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-022-02827-7

Background Excessive daytime sleepiness (EDS) is a cardinal symptom of narcolepsy and affects many patients with obstructive sleep apnoea (OSA). EDS is associated with reduced quality of life, increased accident...


Conclusions: This study demonstrates the impact of sleepiness on quality of life (QoL) and its negative impact irrespective of sleep condition (OSA or narcolepsy). The breakpoint identified is relatively consistent with the established ESS cutoff score ≥ 11, which demarcates pathological sleepiness. Furthermore, as EDS severity worsens...

  • Saved
Changes in Sleep Pattern During the COVID-19 Lockdown in Patients With Narcolepsy, Idiopathic Hypersomnia, and Restless Legs Syndrome

Changes in Sleep Pattern During the COVID-19 Lockdown in Patients With Narcolepsy, Idiopathic Hypersomnia, and Restless Legs Syndrome

Source : https://n.neurology.org/content/early/2022/08/01/WNL.0000000000200907

Background and Objectives: To explore the first COVID-19 lockdown impact on sleep symptoms in patients with narcolepsy, idiopathic hypersomnia (IH) and restless legs syndrome (RLS).


Conclusion: During the lockdown, all patients reported later bedtimes; those with narcolepsy and IH extended their sleep duration unlike RLS patients. These changes were often associated with negative consequences on QoL. In the current context of recurrent COVID-19 waves, the recent development of teleconsultations should enable physicians to...

  • 4yr
    Development of teleconsultations helpful to evaluate patients with sleep disorder
  • Saved
Orexin Receptor Antagonists and Insomnia - Current Psychiatry Reports

Orexin Receptor Antagonists and Insomnia - Current Psychiatry Reports

Source : https://link.springer.com/article/10.1007/s11920-022-01357-w

Purpose of Review We review recent evidence on the use of orexin receptor antagonists (ORAs) for treating insomnia. We evaluate studies on five dual ORAs and one selective ORA. Recent...


Summary: High-quality clinical trials in insomnia populations are needed which directly compare authorized ORAs and investigate non-approved ORAs, the use of ORAs in comorbid insomnia, and the orexin signaling system pathophysiology in insomnia.

  • 4yr
    Helpful to evaluate the use of orexin receptor antagonists (ORAs) for treating insomnia.